Active ingredientRifaximinCat. No. P-R056-001CAS 80621-81-4Family · Pharmaceutical analytical standards
Rifaximin
A semi-synthetic antibiotic of the rifamycin family that is barely absorbed and acts in the gut; first approved in Italy in 1987, it is used for travellers' diarrhoea and hepatic encephalopathy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The rifamycins it derives from were isolated in 1957 by Piero Sensi and colleagues from a soil bacterium found in a French pine forest: the name was inspired by the French gangster film Rififi.
Go to the active ingredient →Active ingredientRifaximinCat. No. P-R056-001CAS 80621-81-4
Pharmacopoeial impurityRifaximin EP Impurity ACat. No. P-R056-002CAS 695-34-1
Pharmacopoeial impurityRifaximin EP Impurity CCat. No. P-R056-003CAS 6998-60-3
Pharmacopoeial impurityRifaximin EP Impurity DCat. No. P-R056-004
Pharmacopoeial impurityRifaximin EP Impurity ECat. No. P-R056-005CAS 13553-79-2
Pharmacopoeial impurityRifaximin EP Impurity FCat. No. P-R056-006CAS 14487-05-9
Pharmacopoeial impurityRifaximin EP Impurity GCat. No. P-R056-007CAS 80621-76-7
Pharmacopoeial impurityRifaximin EP Impurity HCat. No. P-R056-008CAS 1210022-90-4
Isotopically labelledRifaximin-d6Cat. No. P-R056-011CAS 1262992-43-7
Impurity25-Desacetyl RifaximinCat. No. P-R056-012CAS 80621-88-1
ImpurityRifaximin Impurity 1Cat. No. P-R056-013CAS 1351775-03-5
ImpurityRifaximin Impurity 2Cat. No. P-R056-014No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceRifaximin CRSEDQM code Y0001074Family RifaximinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.